Detalles de la búsqueda
1.
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study.
Circulation
; 119(25): 3215-22, 2009 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-19528337
2.
Emergency coronary and peripheral arteries combined with percutaneous intervention in the elderly: success or therapeutic excess?
Future Cardiol
; 11(5): 521-4, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26403439
3.
Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy.
J Am Coll Cardiol
; 56(18): 1447-55, 2010 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-20951320
4.
Safety, efficacy and long-term durability of endovascular therapy for carotid artery disease: the tailored-Carotid Artery Stenting Experience of a single high-volume centre (tailored-CASE Registry).
EuroIntervention
; 5(5): 589-98, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20142180
5.
Cutting balloon angioplasty in percutaneous carotid interventions.
J Endovasc Ther
; 15(6): 655-62, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19090627
6.
Stent migration as a late complication following carotid angioplasty and stenting.
EuroIntervention
; 4(3): 397-9; discussion 400-4, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19110815
7.
Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R). Rationale for the study and protocol design.
Cardiovasc Drugs Ther
; 22(4): 313-20, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18561010
8.
[Accurate risk stratification allows the identification of patients who may benefit from revascularization]. / Un'attenta stratificazione del rischio identifica i pazienti che beneficiano della rivascolarizzazione.
G Ital Cardiol (Rome)
; 10(10): 671-6; discussion 676, 2009 Oct.
Artículo
en Italiano
| MEDLINE | ID: mdl-19960773
Resultados
1 -
8
de 8
1
Próxima >
>>